December 12, 2022 - Daily Market Briefing

Ben and Tom discuss Amgen’s talks to buy Horizon Therapeutics in a deal with north of $20 billion. Developments in Exergonic nuclear fusion show signs of being the best possible future for clean energy, but there is still a long road ahead in perfecting the process. CPI numbers release later this week, so there will be a push in the market one way or the other for sure.For information on how to join the Zoom calls live each morning at 8:30 EST, visit https://www.narwhalcapital.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhalcapital.com/disclosure